BioCentury
ARTICLE | Regulation

A glimpse at FDA’s vaccine panel ahead of October’s COVID-19 meeting

September 4, 2020 9:46 PM UTC

As FDA’s October advisory committee meeting on COVID-19 vaccines approaches, at least three standing members have signaled publicly that authorization and distribution of a vaccine should not be rushed without scientific evidence. 

A roster of the members of the Vaccines and Related Biological Products Advisory Committee resides on FDA’s website; however, the agency last updated the posting in April, and such meetings typically include additional specialists. A spokesperson for FDA’s Center for Biologics Evaluation and Research told BioCentury the draft meeting roster will be available two days before the virtual Oct. 22 meeting...